These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26631390)

  • 1. CD30-positive Cutaneous Pseudolymphoma Caused by Tocilizumab in a Patient with Rheumatoid Arthritis: Case Report and Literature Review.
    Inoue A; Sawada Y; Ohmori S; Omoto D; Haruyama S; Yoshioka M; Nishio D; Nakamura M
    Acta Derm Venereol; 2016 May; 96(4):570-1. PubMed ID: 26631390
    [No Abstract]   [Full Text] [Related]  

  • 2. Tocilizumab-induced pustular drug eruption.
    Mori T; Yamamoto T
    Int J Rheum Dis; 2017 Nov; 20(11):1776-1777. PubMed ID: 26218136
    [No Abstract]   [Full Text] [Related]  

  • 3. Valsartan-induced drug eruption followed by CD30+ pseudolymphomatous eruption.
    Sawada Y; Yoshiki R; Kawakami C; Fukamachi S; Sugita K; Nakamura M; Tokura Y
    Acta Derm Venereol; 2010 Sep; 90(5):521-2. PubMed ID: 20814632
    [No Abstract]   [Full Text] [Related]  

  • 4. Cutaneous pseudolymphoma associated with a TNF-alpha inhibitor treatment: etanercept.
    Guis S; Schiano de Colella JM; Bonnet N; Andrac-Meyer L; Balandraud N; Mattei JP; Franck B; Roudier C; Roudier J; Berbis P
    Eur J Dermatol; 2008; 18(4):474-6. PubMed ID: 18573737
    [No Abstract]   [Full Text] [Related]  

  • 5. Erythrodermic CD8+ pseudolymphoma during infliximab treatment in a patient with psoriasis: use of cyclosporine as a rescue therapy.
    Safa G; Luce K; Darrieux L; Tisseau L; Ortonne N
    J Am Acad Dermatol; 2014 Oct; 71(4):e149-50. PubMed ID: 25219741
    [No Abstract]   [Full Text] [Related]  

  • 6. Cutaneous pseudolymphoma occurring during methotrexate therapy for rheumatoid arthritis.
    Flipo RM; Delaporte E; Lecomte-Houcke M
    J Rheumatol; 1997 Apr; 24(4):809-10. PubMed ID: 9101529
    [No Abstract]   [Full Text] [Related]  

  • 7. CD30-positive T-cell pseudolymphoma induced by amlodipine.
    Kabashima R; Orimo H; Hino R; Nakashima D; Kabashima K; Tokura Y
    J Eur Acad Dermatol Venereol; 2008 Dec; 22(12):1522-4. PubMed ID: 18452522
    [No Abstract]   [Full Text] [Related]  

  • 8. Cutaneous sarcoidosis in a patient with rheumatoid arthritis receiving tocilizumab.
    Shono Y; Kamata M; Takeoka S; Ikawa T; Tateishi M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Asako K; Kono H; Tada Y
    J Dermatol; 2018 Aug; 45(8):e217-e218. PubMed ID: 29500868
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cutaneous pseudolymphoma with two types of anti-TNFα: a class effect?].
    Schmutz JL; Trechot P
    Ann Dermatol Venereol; 2012 Oct; 139(10):695-6. PubMed ID: 23122389
    [No Abstract]   [Full Text] [Related]  

  • 10. Visceral leishmaniasis infection during adalimumab therapy: a case report and literature review.
    Tung Chen Y; Perales C; Lacruz J; Senent L; Salavert M
    Int J Rheum Dis; 2014 Sep; 17(7):822-4. PubMed ID: 24980576
    [No Abstract]   [Full Text] [Related]  

  • 11. Ramsay Hunt syndrome associated with tocilizumab therapy in rheumatoid arthritis: a case report.
    Mimata Y; Akasaka T; Nakano R; Murata T; Kawashima M; Shimamura T
    Int J Rheum Dis; 2013 Jun; 16(3):367-8. PubMed ID: 23981764
    [No Abstract]   [Full Text] [Related]  

  • 12. Pseudolymphoma occurring in a tattoo.
    Kahofer P; El Shabrawi-Caelen L; Horn M; Kern T; Smolle J
    Eur J Dermatol; 2003; 13(2):209-12. PubMed ID: 12695144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rheumatoid neutrophilic dermatitis in a patient taking tocilizumab for treatment of rheumatoid arthritis.
    Kubota N; Ito M; Sakauchi M; Kobayashi K
    J Dermatol; 2017 Jul; 44(7):e180-e181. PubMed ID: 28342172
    [No Abstract]   [Full Text] [Related]  

  • 14. Cutaneous lupus erythematosus induced by golimumab therapy.
    Al Izzi M; Reda A
    Int J Rheum Dis; 2017 Dec; 20(12):2159-2161. PubMed ID: 27458030
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and safety of tocilizumab combined with cyclosporine A in a patient with rheumatoid arthritis and concomitant chronic hepatitis C virus infection.
    Giannitti C; Fineschi I; Frediani B; Fioravanti A; Galeazzi M
    Clin Exp Rheumatol; 2013; 31(5):816. PubMed ID: 24021246
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of necrotising fasciitis in a patient treated for rheumatoid arthritis with tocilizumab.
    Hashimoto N; Yamaoka T; Koguchi-Yoshioka H; Tanaka A; Tanemura A; Azukizawa H; Murota H; Kang J; Nakagawa Y; Shimazu T; Katayama I
    Acta Derm Venereol; 2015 Mar; 95(3):370-1. PubMed ID: 25138684
    [No Abstract]   [Full Text] [Related]  

  • 17. Cutaneous pseudolymphoma after patch test to gold sodium thiosulfate in two patients.
    García-Arpa M; Gómez-Torrijos E; Relea-Calatayud F; Santiago-Sánchez Mateos JL; Galindo-Bonilla PA; Carmona-Rodríguez M
    Contact Dermatitis; 2020 May; 82(5):322-324. PubMed ID: 31925792
    [No Abstract]   [Full Text] [Related]  

  • 18. Rheumatoid factor appearance after tocilizumab treatment seems to predict bad therapeutical response in rheumatoid arthritis.
    Faillace C; de Carvalho JF
    Rheumatol Int; 2013 Jul; 33(7):1909-10. PubMed ID: 22441966
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypersensitivity reactions to tocilizumab: role of skin tests in diagnosis.
    Rocchi V; Puxeddu I; Cataldo G; Del Corso I; Tavoni A; Bazzichi L; Bombardieri S; Migliorini P
    Rheumatology (Oxford); 2014 Aug; 53(8):1527-9. PubMed ID: 24899663
    [No Abstract]   [Full Text] [Related]  

  • 20. Cutaneous intravascular CD30+ T-cell pseudolymphoma occurring in a regressing keratoacanthoma.
    Kailas A; Elston DM; Crater SE; Cerruto CA
    J Cutan Pathol; 2018 Apr; 45(4):296-298. PubMed ID: 29369392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.